Document Detail


The future of discovery chemistry: quo vadis? Academic to industrial--the maturation of medicinal chemistry to chemical biology.
MedLine Citation:
PMID:  20149893     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
At Roche, we set out to think about the future role of medicinal chemistry in drug discovery in a project involving both Roche internal stakeholders and external experts in drug discovery chemistry. To derive a coherent strategy, selected scientists were asked to take extreme positions and to derive two orthogonal strategic options: chemistry as the traditional mainstream science and chemistry as the central entrepreneurial science. We believe today's role of medicinal chemistry in industry has remained too narrow. To provide the innovation that industry requires, medicinal chemistry must play its part and diversify at pace with our increasing understanding of chemical biology and network pharmacology.
Authors:
Torsten Hoffmann; Cheryl Bishop
Related Documents :
16584323 - Purdue university-banfield national companion animal surveillance program for emerging ...
11149973 - Osler's pathology.
22415613 - Ligand binding assays in the 21st century laboratory: recommendations for characterizat...
Publication Detail:
Type:  Journal Article     Date:  2010-02-10
Journal Detail:
Title:  Drug discovery today     Volume:  15     ISSN:  1878-5832     ISO Abbreviation:  Drug Discov. Today     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-04-05     Completed Date:  2010-06-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9604391     Medline TA:  Drug Discov Today     Country:  England    
Other Details:
Languages:  eng     Pagination:  260-4     Citation Subset:  IM    
Copyright Information:
2010 Elsevier Ltd. All rights reserved.
Affiliation:
F. Hoffmann-La Roche, Grenzacherstrasse 124, PRCB, Building 92/8.88, CH-4070 Basel, Switzerland. cheryl.l.bishop@uk.pwc.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Academic Medical Centers / trends*
Chemistry, Pharmaceutical / trends*
Drug Discovery / trends*
Drug Industry / trends*
Molecular Biology / trends*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Stem cell therapies for ocular surface disease.
Next Document:  Evaluation of different cytotoxic and cytostatic measures for the in vitro micronucleus test (MNVit)...